Allianz Asset Management
SGMO

Allianz Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Allianz Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-83,245
Closed -$1.3M – 2284
2020
Q4 		$1.3M Buy
+83,245
New +$975K ﹤0.01% 1429
2020
Q1 		– Sell
-167,063
Closed -$1.4M – 2717
2019
Q4 		$1.4M Buy
167,063
+8,025
+5% +$73.8K ﹤0.01% 2046
2019
Q3 		$1.45M Buy
159,038
+47
+0% +$527 ﹤0.01% 1965
2019
Q2 		$1.71M Sell
158,991
-120,924
-43% -$1.29M ﹤0.01% 1935
2019
Q1 		$2.67M Sell
279,915
-50,564
-15% -$516K ﹤0.01% 1735
2018
Q4 		$3.77M Sell
330,479
-48,068
-13% -$597K ﹤0.01% 1523
2018
Q3 		$6.42M Buy
378,547
+107,872
+40% +$1.64M 0.01% 1454
2018
Q2 		$3.84M Buy
270,675
+27,033
+11% +$449K ﹤0.01% 1645
2018
Q1 		$4.63M Buy
243,642
+137,050
+129% +$2.93M ﹤0.01% 1567
2017
Q4 		$1.75M Buy
+106,592
New +$1.59M ﹤0.01% 2063
2015
Q3 		– Sell
-86,405
Closed -$959K – 2413
2015
Q2 		$959K Sell
86,405
-591,923
-87% -$7.63M ﹤0.01% 1975
2015
Q1 		$10.6M Sell
678,328
-20,067
-3% -$310K 0.01% 932
2014
Q4 		$10.6M Buy
698,395
+395,104
+130% +$4.8M 0.01% 936
2014
Q3 		$3.27M Sell
303,291
-7,122
-2% -$93K ﹤0.01% 1242
2014
Q2 		$4.74M Sell
310,413
-17,301
-5% -$249K 0.01% 952
2014
Q1 		$5.92M Sell
327,714
-9,147
-3% -$176K 0.01% 912
2013
Q4 		$4.68M Sell
336,861
-9,496
-3% -$109K 0.01% 967
2013
Q3 		$3.63M Buy
346,357
+24,257
+8% +$241K ﹤0.01% 1019
2013
Q2 		$2.52M Buy
+322,100
New +$2.81M ﹤0.01% 1136

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Allianz Asset Management's SGMO Position: Q1 2021 in Review

Allianz Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2021, closing a stake of 83,245 shares — an estimated $1.3M sold.

Allianz Asset Management first reported a position in SGMO in Q2 2013 and held it in 19 quarters. The position peaked at $10.6M in Q1 2015. 203 funds tracked by Wall St. Rank hold SGMO as of Q1 2021.

  • Allianz Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2021 after selling out during the quarter.
  • Allianz Asset Management sold 83,245 SANGAMO THERAPEUTICS INC shares in Q1 2021, an estimated $1.3M.
  • Allianz Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 19 quarters.
  • Allianz Asset Management's SANGAMO THERAPEUTICS INC position peaked at $10.6M in Q1 2015.
  • 203 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2021.

Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.